Ranked #8,248 of 8,699 institutional investors
Omega Fund Management, LLC
Boston, MA
$81.8M
US stock portfolio at live prices · today +$1.1M (+1.34%)
Live prices, last trade 10:15 AM ET
- Value at quarter end (Q3 2026)
- $125M
- Change from Q2 2026
- −$60.5M (−32.59%)
- Positions
- 8 · 1 new, 1 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$12.0M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesNUVB 34.0%BCAX 19.5%BBNX 16.1%BBOT 7.72%IMUX 3.82%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| NUVB Nuvation Bio Inc. | 7,151,031 | $27.9M | 34.0% | Reduced −12% |
| BCAX Bicara Therapeutics Inc. | 1,759,912 | $16.0M | 19.5% | Reduced −3% |
| BBNX Beta Bionics, Inc. | 962,010 | $13.2M | 16.1% | Reduced −27% |
| BBOT BridgeBio Oncology Therapeutics, Inc. | 3,289,661 | $6.3M | 7.72% | Unchanged |
| IMUX Immunic, Inc. | 430,180 | $3.1M | 3.82% | New |
| IMA ImageneBio, Inc. | 455,361 | $1.8M | 2.22% | Unchanged |
| SANA Sana Biotechnology, Inc. | 843,750 | $1.4M | 1.77% | Unchanged |
| ODTX Odyssey Therapeutics, Inc. | 2,893 | $49K | <0.1% | Unchanged |
Sold out in Q3 2026
| Stock | Shares held at Q2 2026 | Worth today |
|---|---|---|
| ALMS Alumis Inc. | 241,255 | $1.0M |